Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase-Reference-Cited by-同舟云学术

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Published:2020-02-20 Issue:7 Volume:115 Page:1066-1074
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Murillo Perez Carla F.,Harms Maren H.,Lindor Keith D.,van Buuren Henk R.,Hirschfield Gideon M.,Corpechot Christophe,van der Meer Adriaan J.,Feld Jordan J.,Gulamhusein Aliya,Lammers Willem J.,Ponsioen Cyriel Y.,Carbone Marco,Mason Andrew L.,Mayo Marlyn J.,Invernizzi Pietro,Battezzati Pier Maria,Floreani Annarosa,Lleo Ana,Nevens Frederik,Kowdley Kris V.,Bruns Tony,Dalekos George N.,Gatselis Nikolaos K.,Thorburn Douglas,Trivedi Palak J.,Verhelst Xavier,Parés Albert,Janssen Harry L.A.,Hansen Bettina E.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Primary biliary cirrhosis;Kaplan;N Engl J Med,2005

2. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study;Lammers;Gastroenterology,2014

3. Serum bilirubin: A prognostic factor in primary biliary cirrhosis;Shapiro;Gut,1979

4. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis;Bonnand;Hepatology,1999

5. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr Cohort Study involving 297 patients;ter Borg;Am J Gastroenterol,2006

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis;Digestive and Liver Disease;2024-09

3. Primary biliary cholangitis;The Lancet;2024-09

4. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study;JHEP Reports;2024-08

5. Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-07-22